New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.
Tanaka A, Giustino G, Briede I, Sawaya FJ, Daemen J, Kawamoto H, Meliga E, D'Ascenzo F, Cerrato E, Stefanini GG, Capodanno D, Mangiameli A, Templin C, Erglis A, Morice MC, Mehran R, Van Mieghem NM, Nakamura S, De Benedictis M, Pavani M, Varbella F, Pisaniello M, Sharma SK, Tamburino C, Tchetche D, Colombo A, Chieffo A; DELTA 2 Investigators.
Tanaka A, et al. Among authors: giustino g.
Int J Cardiol. 2019 Apr 1;280:30-37. doi: 10.1016/j.ijcard.2018.12.003. Epub 2018 Dec 15.
Int J Cardiol. 2019.
PMID: 30595357
Clinical Trial.